{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Demerol (meperidine hydrochloride) is a prescription opioid pain reliever used to manage moderate to severe pain. It comes in tablets (50mg, 100mg), injectables (25-100mg/ml), and syrup (50mg/5ml), but all forms are discontinued. As a Schedule II controlled substance, it carries risks of addiction and misuse. Consult a doctor for alternatives. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Meperidine hydrochloride \u2014 ANDA 080445 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=080445", "mediaType": "text/html", "title": "Meperidine hydrochloride"}], "identifier": "ANDA080445", "issued": "2016-09-16", "keyword": ["drug-manufacturers", "health-care", "medications", "pharmaceuticals", "prescription-drugs"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Meperidine hydrochloride"}